Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4091887
Max Phase: Preclinical
Molecular Formula: C22H18Cl2F2N2O7S3
Molecular Weight: 627.50
Molecule Type: Small molecule
Associated Items:
ID: ALA4091887
Max Phase: Preclinical
Molecular Formula: C22H18Cl2F2N2O7S3
Molecular Weight: 627.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=S(=O)(c1cc(N(S(=O)(=O)c2cccc(F)c2)S(=O)(=O)c2cccc(F)c2)c(Cl)cc1Cl)N1CCOCC1
Standard InChI: InChI=1S/C22H18Cl2F2N2O7S3/c23-19-13-20(24)22(38(33,34)27-7-9-35-10-8-27)14-21(19)28(36(29,30)17-5-1-3-15(25)11-17)37(31,32)18-6-2-4-16(26)12-18/h1-6,11-14H,7-10H2
Standard InChI Key: UZLNSHZZJBQADE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 627.50 | Molecular Weight (Monoisotopic): 625.9621 | AlogP: 3.88 | #Rotatable Bonds: 7 |
Polar Surface Area: 118.13 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.39 | CX LogD: 4.39 |
Aromatic Rings: 3 | Heavy Atoms: 38 | QED Weighted: 0.39 | Np Likeness Score: -1.62 |
1. Banerjee S, Norman DD, Lee SC, Parrill AL, Pham TC, Baker DL, Tigyi GJ, Miller DD.. (2017) Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells., 60 (4): [PMID:28112925] [10.1021/acs.jmedchem.6b01270] |
Source(1):